Showing results (221-230 of 439) with videos related to
Sort By:
Pageof 44
European Journal of Heart Failure|May 27, 2020
Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCATJoão Pedro Ferreira, Xavier Rossello, Stuart J Pocock, et al.American Heart Journal|December 25, 2015
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialsJosephine Warren, Roxana Mehran, Usman Baber, et al.European Heart Journal|July 19, 2013
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trialTimothy J Collier, Stuart J Pocock, John J V McMurray, et al.European Journal of Heart Failure|May 6, 2020
Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysisDavid Messika-Zeitoun, Patrick Verta, John Gregson, et al.European Journal of Heart Failure|February 21, 2020
Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trialsXavier Rossello, João Pedro Ferreira, Stuart J Pocock, et al.Lancet (London, England)|September 3, 2020
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trialsFaiez Zannad, João Pedro Ferreira, Stuart J Pocock, et al.Clinical Cardiology|January 23, 2020
Prolonged dual antiplatelet therapy in patients with non-ST-segment elevation myocardial infarction: 2-year findings from EPICOR AsiaYanan Zou, Shuang Yang, Shipeng Wang, et al.European Journal of Heart Failure|April 17, 2023
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillationGerasimos Filippatos, Dimitrios Farmakis, Javed Butler, et al.Journal of the American College of Cardiology|August 29, 2023
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection FractionShingo Matsumoto, Toru Kondo, Pardeep S Jhund, et al.Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.Pageof 44